Adagrasib (Ada) + cetuximab (Cetux) for KRAS(G12C)-mutated metastatic colorectal cancer (mCRC): Longer follow-up analysis from KRYSTAL-1 Meeting Abstract
| Authors: | Yaeger, R.; Uboha, N. V.; Klempner, S. J.; Bekaii-Saab, T. S.; Sabari, J. K.; Barve, M. A.; Saltzman, J. N.; Peguero, J. A.; Paulson, A. S.; Jänne, P. A.; Pelster, M.; Cruz-Correa, M.; Kim, A. M. K.; Hu, N.; Ahmad, H. A.; Kopetz, S. |
| Abstract Title: | Adagrasib (Ada) + cetuximab (Cetux) for KRAS(G12C)-mutated metastatic colorectal cancer (mCRC): Longer follow-up analysis from KRYSTAL-1 |
| Meeting Title: | 2025 ASCO Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2025 Jan 23-25 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-02-01 |
| DOI: | 10.1200/JCO.2025.43.4_suppl.131 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl plus with full text |
| DOI/URL: | |
| Notes: | Meeting Abstract: 131 -- Source: CINAHL Plus with Full Text |
